Omeza OCM is an FDA 510(k)-cleared wound matrix designed to support all phases of healing in diabetic foot ulcers, venous ulcers, pressure ulcers, and complex chronic wounds — with CMS-exempt positioning that gives forward-thinking practices a distinct advantage.
Request Information
A Fortify Medical representative will follow up within 24 hours.
About Omeza OCM
Omeza OCM is positioned as a first-of-its-kind drug-device combination wound matrix made with cold water fish peptides. Unlike sheet-based skin substitutes, OCM is an amorphous solid designed to conform to irregular wound beds and support all four phases of wound healing in a single application.
How It Works
Omeza OCM™ is created through a proprietary process that produces an amorphous solid capable of conforming to the wound bed — including tunnels and undermined areas — providing comprehensive support across all healing phases.
Clinical Evidence
Omeza OCM is supported by a registered clinical study and growing provider feedback across wound care specialties. With over 60% positive application response rates reported, OCM delivers measurable outcomes in stalled and chronic wounds.
Comprehensive Wound Healing
OCM is designed to address the key biological needs across all phases of wound healing — something most single-mechanism products cannot provide.
Reduces biofilm formation and supports a healthy inflammatory response to prepare the wound bed for healing.
Provides molecules that signal tissues to grow and proliferate, accelerating the rebuilding of wound architecture.
Delivers scaffolding for skin to regrow on, supporting the structural restoration of tissue layers.
Inhibits bacterial colonization and disrupts biofilm formation in chronic wounds where infection risk is elevated.
Practice Support
Fortify Medical supports providers across all major care environments.
Support for diabetic foot ulcers, venous leg ulcers, and complex chronic wound cases.
Resources for teams managing high-acuity, hard-to-heal chronic wounds at scale.
Information for providers serving patients across SNFs, home settings, and assisted living.
Product information for teams managing pressure ulcers in long-term care settings.
Resources for chronic wounds, venous stasis ulcers, and difficult wound management.
Support for post-operative wounds, vascular ulcers, and complex wound management.
Wound matrix support for surgical wounds, trauma wounds, and complex reconstructive cases.
Wound management resources for primary care physicians supporting chronic wound populations.
Provider Feedback
Feedback from clinicians managing real patients in podiatry, mobile wound care, and wound care center settings.
"Omeza collagen matrix is easily applied, easily maintained and nearly every patient with whom we've used it has gone on to improvement or full healing within the 3rd or 4th application."
"After the first two treatments, I was most impressed by the positive qualitative change to the wound bed with robust granulation tissue forming. The wound quickly epithelialized and was healed."
"After 37 years of wound care experience, having tried everything in a wound care center setting, I can only suggest drop what you are using and try Omeza. The results are astounding."
"Variable application concept, lidocaine, collagen (matrix), skin protectant, with an easy application process. Amazing results for my patients with chronic non-healing wounds!"
"After about three months of using Omeza, I can finally say my patient's wound is healed. Before using Omeza, the patient's wound had stalled in healing, and this amazing product definitely helped kickstart the healing process."
"I went into our case study looking to improve skin and wounds on long term patients. The response to the Omeza treatment protocol was greater than expected and healed 3 wounds that were present for greater than a year."
Reimbursement Positioning
While most advanced wound products are subject to the flat $127.14/cm² CMS cap, Omeza OCM is positioned as a non-sheet product that may qualify for carrier-priced reimbursement through local Medicare Administrative Contractors.
Stable reimbursement positioning means you can continue offering advanced wound care without financial uncertainty.
Continued access to comprehensive wound healing technology without restrictions imposed by pricing caps.
A competitive advantage with one of the few advanced wound care products exempt from the new flat rate cap.
Common Questions
Our Team
Fortify Medical is an authorized distributor of Omeza OCM, dedicated to supporting wound care practices nationwide with clinical resources, reimbursement guidance, and direct representative access.
Ready to Evaluate OCM?
Talk with a Fortify Medical representative about product information, clinical resources, and reimbursement support for your practice.